Analysis of the CD47-TSP1-CD36 pathway in CD4+CD28− T cells from RA patients resulted in a comparable production of IL-2 and proliferation rates as observed for the CD28 pathway. This evidence concerns the gene CD4 and rheumatoid arthritis.